IRIS

DE VITA, GABRIELLA

DE VITA, GABRIELLA  

DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE  

Mostra records
Risultati 1 - 20 di 71 (tempo di esecuzione: 0.049 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. 1.1 Articolo in rivista 2001 Melillo, ROSA MARINA; Carlomagno, Francesca; DE VITA, Gabriella; Formisano, Pietro; Vecchio, Giancarlo; Fusco, Alfredo; Billaud, M.; Santoro, Massimo
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. 1.1 Articolo in rivista 1997 Carlomagno, Francesca; G., Salvatore; A. M., Cirafici; DE VITA, Gabriella; Melillo, ROSA MARINA; V. d., Franciscis; M., Billaud; Fusco, Alfredo; Santoro, Massimo
Molecular biology of the MEN2 gene 1.1 Articolo in rivista 1998 Santoro, M; Melillo, ROSA MARINA; Carlomagno, Francesca; Visconti, R; DE VITA, Gabriella; Salvatore, G; Lupoli, G; Fusco, Alfredo; Vecchio, G.
Molecular heterogeneity of RET loss of function in Hirschsprung's disease 1.1 Articolo in rivista 1996 Carlomagno, Francesca; DE VITA, Gabriella; Berlingieri, Mt; DE FRANCISCIS, V; Melillo, ROSA MARINA; Colantuoni, V; Kraus, Mh; DI FIORE, Pp; Fusco, Alfredo; Santoro, M.
Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells. 1.1 Articolo in rivista 1995 D'Alessio, A; DE VITA, Gabriella; Cal, G; Nitsch, Lucio; Fusco, Alfredo; Vecchio, G; Santelli, G; Santoro, M; DE FRANCISCIS, V.
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 1.1 Articolo in rivista 2000 DE VITA, Gabriella; Melillo, ROSA MARINA; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M.
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 1.1 Articolo in rivista 1998 Carlomagno, F.; Melillo, ROSA MARINA; Visconti, R.; Salvatore, G.; DE VITA, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.
Association between the expression of E1A oncogene and increased sensitivity to growth inhibition induced by sustained levels of cAMP in rat thyroid cells 1.1 Articolo in rivista 2000 Villone, G; DE VITA, Gabriella; Chieffi, P; Picascia, A; Stanzione, R; Santoro, M; Fusco, Alfredo; Tramontano, Donatella; EUR J., Endocrinol
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase 1.1 Articolo in rivista 2007 DE FALCO, V; Castellone, Md; DE VITA, Gabriella; Cirafici, Am; Hershman, Jm; Guerrero, C; Fusco, Alfredo; Melillo, ROSA MARINA; Santoro, Massimo
The microRNA-Processing Enzyme Dicer Is Essential for Thyroid Function 1.1 Articolo in rivista 2011 Frezzetti, D.; Reale, C.; Calì, G.; Nitsch, Lucio; Fagman, H.; Nilsson, O.; Scarfò, M.; DE VITA, Gabriella; DI LAURO, Roberto
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells 1.1 Articolo in rivista 1996 D., Califano; D'Alessio, A.; COLUCCI DAMATO, L.; DE VITA, Gabriella; Monaco, C.; Santelli, G.; DI FIORE, P. P.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.; DE FRANCISCIS, V.
Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines. 1.1 Articolo in rivista 1998 S., Chappuis Flament; A., Pasini; DE VITA, Gabriella; C., Ségouffin Cariou; Fusco, Alfredo; T., Attié; G. M., Lenoir; Santoro, Massimo; M., Billaud
MicroRNAs 8.02 Comunicazioni a Convegni o Seminari 2007 DE VITA, Gabriella
modello animale per lo studio di sostanze ad attività cardioterapeutica ed anti-ipertensiva 6.1 Brevetto 2004 Potenza, N; DI LAURO, Roberto; DE VITA, Gabriella; Lembo, G.
miR-21 deregulation in thyroid cancer 1.5 Abstract in rivista 2008 Frezzetti, Daniela; Guerra, C; Barbacid, M; DI LAURO, Roberto; DE VITA, Gabriella
Role of wnt4 in thyroid cancer 1.5 Abstract in rivista 2009 DE MENNA, Marta; Mancini, D; Ferraro, A; DI LAURO, Roberto; DE VITA, Gabriella
Dose-dependent inhibition of thyroid differentiation by RAS oncogenes. 1.1 Articolo in rivista 2005 DE VITA, Gabriella; Bauer, L; DA COSTA, Vm; DE FELICE, Mario; Baratta, Mg; DE MENNA, M; DI LAURO, Roberto
Association between the expression of E1 A oncogene and increased sensitivity to growth inhibition induced by sustained levels of cAMP in rat thyroid cells 1.1 Articolo in rivista 2000 Villone, G.; DE VITA, Gabriella; Chieffi, P.; Picascia, A.; Stanzione, R.; Santoro, M.; Fusco, Alfredo; Tramontano, Donatella
Expression of Homeobox-containing Genes In Primary and Metastatic Colorectal-cancer 1.1 Articolo in rivista 1993 DE VITA, Gabriella; P., Barba; N., Odartchenko; J. C., Givel; G., Freschi; G., Bucciarelli; M. C., Magli; E., Boncinelli; C., Cillo
Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells. 1.1 Articolo in rivista 1995 Califano, D.; Monaco, C.; DE VITA, Gabriella; D'Alessio, A.; Dathan, N. A.; Possenti, R.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, Massimo; de Franciscis, V.